Komori
Koa Shoji Holdings (9273) · InitiativeRestated

Joint Development and Outsourcing with Overseas Pharmaceutical Companies

First written in FY2018. 2 of 3 entries say "Restated". Latest entry: FY2021.

3entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018 – FY20212018: 120182019: 120192020: 020202021: 12021
Same theme, other companies
Enhancing technological capabilities through technology partnerships with overseas companiesA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2021RestatedAnnual report

    「The company is also engaged in joint development with overseas pharmaceutical companies, targeting products with advantages in patentability as well as oral drugs already marketed overseas to shorten development time.」

    The company has reconfirmed its policy on targets for joint development and external contracting with overseas pharmaceutical companies.
  2. FY2019RestatedAnnual report

    「The company is also engaged in joint development with overseas pharmaceutical companies, targeting products with advantages in patentability as well as oral drugs already marketed overseas to shorten development time.」

    The company has reconfirmed its policy on targets for joint development and external use of technologies with overseas pharmaceutical companies.
  3. FY2018First statedAnnual report

    「The company is also engaged in joint development with overseas pharmaceutical companies, targeting products with advantages in patentability as well as oral drugs already marketed overseas to shorten development time.」

    A measure to use overseas technologies for products offering patent advantages or the potential to shorten development time.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Koa Shoji Holdings's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Joint Development and Outsourcing with Overseas Pharmaceutical Companies | KOA SHOJI HOLDINGS CO.,LTD. (9273) | Komori